Clinical Trials List
Protocol NumberTMC114-C226
2006-08-01 - 2008-12-01
Phase III
Study ended1
-
Sponsor
-
Trial scale
-
Update
2025/08/20
Investigators and Locations
Principal Investigator
王永衛
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
5000 participants
